Corrigendum to “Physiologically-based pharmacokinetic modeling of natalizumab for multiple sclerosis patients to predict the withdrawal time in pregnancy and vaccine time in infants” [European Journal of Pharmaceutical Sciences, 215 (2025), 107301]

European Journal of Pharmaceutical Sciences 2026 Open access

Read full text

Authors: Peilin Zhou, Chenming Zhong, Wanhong Wu, Meng Ke, J X Xu, Rongfang Lin, Pinfang Huang, Cuihong Lin

DOI: 10.1016/j.ejps.2025.107420

Cited by: 0

Fields of Study & Subjects

Multiple Sclerosis Research Studies Prenatal Screening and Diagnostics Reproductive System and Pregnancy